Tag: athenex

November 14, 2018

Athenex Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of...
October 29, 2018

Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials

Athenex (Nasdaq:ATNX) a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of...
August 9, 2018

Athenex Pharmaceutical Division Receives FDA Clearance to Import Potassium Chloride Injection Concentrate to Address U.S. Drug Shortage

Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of...
July 18, 2018

Athenex Announces Axis Therapeutics Enters into MOU with Hong Kong Polytechnic University

Athenex (NASDAQ:ATNX) has announced that Axis Therapeutics has entered into an MOU with the Kong Kong Polytechnic University to explore...